WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
US Stock Market Move | The optical communication sector fell across the board, with Lumentum (LITE.US) dropping more than 5%.
Evening Hotspots of A shares | Eight departments issued a joint document! Concerning "Artificial Intelligence + Manufacturing"
US Stock Market Move | Concept of weight-loss drugs is on the rise, Eli Lilly (LLY.US) up over 4% to break historical high.
US Stock Market Move | The optical communication sector fell across the board, with Lumentum (LITE.US) dropping more than 5%.
Evening Hotspots of A shares | Eight departments issued a joint document! Concerning "Artificial Intelligence + Manufacturing"
US Stock Market Move | Concept of weight-loss drugs is on the rise, Eli Lilly (LLY.US) up over 4% to break historical high.
RECOMMEND
Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026
Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026
Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026
